AKT1 and lung cancer: Zeng et al. reported that upregulation miR‐199a‐5p inhibits autophagy and renders resistance to chemotherapeutic drugs in lung cancer cells by activating the PI3K/Akt/mTOR pathway and targeting p62 45.